All Stories

  1. Electromyographic Patterns of Paratonia in Normal Subjects and in Patients with Mild Cognitive Impairment or Alzheimer’s Disease
  2. The role of physical activity against chemotherapy-induced peripheral neuropathy: a narrative review
  3. Near-Infrared Transflectance Spectroscopy Discriminates Solutions Containing Two Commercial Formulations of Botulinum Toxin Type A Diluted at Recommended Volumes for Clinical Reconstitution
  4. Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years
  5. Effectiveness of Botulinum Toxin on Pain in Stroke Patients Suffering from Upper Limb Spastic Dystonia
  6. Habituation of Somatosensory Evoked Potentials in Patients with Alzheimer’s Disease and Those with Vascular Dementia
  7. Italian Public Health Expenditure for Vitamin D is still high: New Outlook to Saving From a Consumption Analysis in the Liguria Region
  8. Serotonergic central tone in Parkinson’s disease with fatigue: Evidence from the loudness dependence of auditory evoked potentials (LDAEP)
  9. Early nociceptive evoked potentials (NEPs) recorded from the scalp
  10. Stroke impairs the control of isometric forces and muscle activations in the ipsilesional arm
  11. I can’t count, but I can beat you playing cards: a case report on autoimmune encephalitis
  12. In vivo non-invasive near-infrared spectroscopy distinguishes normal, post-stroke, and botulinum toxin treated human muscles
  13. Dual task gait deteriorates gait performance in cervical dystonia patients: a pilot study
  14. Effects of Hemispheric Stroke Localization on the Reorganization of Arm Movements within Different Mechanical Environments
  15. Systematic Review of Fatigue in Individuals With Cerebral Palsy
  16. The Effect of Kinesio Taping on Spasticity: A Randomized, Controlled, Double-Blind Pilot Study in Para-Swimmers
  17. Effect of Short-Term Exposure to Supplemental Vibrotactile Kinesthetic Feedback on Goal-Directed Movements after Stroke: A Proof of Concept Case Series
  18. Surface Electromyography Spectral Parameters for the Study of Muscle Fatigue in Swimming
  19. Spasticity, spastic dystonia, and static stretch reflex in hypertonic muscles of patients with multiple sclerosis
  20. Paratonia in Dementia: A Systematic Review
  21. Meralgia Paraesthetica after Prone Position Ventilation in a Patient with COVID-19
  22. Mal de Debarquement Syndrome: A Matter of Loops?
  23. Epilepsy course during COVID-19 pandemic in three Italian epilepsy centers
  24. Transcranial Direct Current Stimulation in the Treatment of Subacute Post-Stroke Thalamic Aphasia
  25. Ghost spasticity in multiple sclerosis
  26. The new micropatterned interdigitated electrode for selective assessment of the nociceptive system
  27. Impact of the 2018 World Para Swimming classification revision on the race results in international Paralympic swimming events
  28. Premotor dorsal white matter integrity for the prediction of upper limb motor impairment after stroke
  29. The Ventricular System Enlarges Abnormally in the Seventies, Earlier in Men, and First in the Frontal Horn: A Study Based on More Than 3,000 Scans
  30. Neuroradiological Evolution of Glycaemic Hemichorea-Hemiballism and the Possible Role of Brain Hypoperfusion
  31. Treadmill training in patients affected by Charcot–Marie–Tooth neuropathy: results of a multicenter, prospective, randomized, single‐blind, controlled study
  32. Self-Perceived Psychophysical Well-Being of Young Competitive Swimmers With Physical or Intellectual Impairment
  33. “Spastic dystonia” or “Inability to voluntary silence EMG activity”? Time for clarifying the nomenclature
  34. Central fatigue and attentional processing in Parkinson’s disease: An event-related potentials study
  35. Spastic dystonia in stroke subjects: prevalence and features of the neglected phenomenon of the upper motor neuron syndrome
  36. The Cerebellum Modulates Attention Network Functioning: Evidence from a Cerebellar Transcranial Direct Current Stimulation and Attention Network Test Study
  37. Outcome measures in the clinical evaluation of ambulatory Charcot-Marie-Tooth 1A subjects
  38. Botulinum toxin is prescribed for spasticity or spastic dystonia?
  39. Training Muscle Synergies to Relearn Movement: Current Perspectives and Future Trends
  40. Training methods and analysis of races of a top level Paralympic swimming athlete
  41. Reader response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study
  42. Is There Full or Proportional Somatosensory Recovery in the Upper Limb After Stroke? Investigating Behavioral Outcome and Neural Correlates
  43. Isolated Demyelination of Corpus Callosum Following Hypoxia
  44. Micropatterned surface electrode for massive selective stimulation of intraepidermal nociceptive fibres
  45. Spasticity and spastic dystonia: the two faces of velocity-dependent hypertonia
  46. Protocol for the study of self-perceived psychological and emotional well-being of young Paralympic athletes
  47. Effects of continuous visual feedback during sitting balance training in chronic stroke survivors
  48. A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity
  49. The many facets of motor learning and their relevance for Parkinson's disease
  50. Radial shock wave therapy: effect on pain and motor performance in a paralympic athlete
  51. Do flexible inter-injection intervals improve the effects of botulinum toxin A treatment in reducing impairment and disability in patients with spasticity?
  52. Brain temperature as a measure of misfolded proteins metabolism
  53. Learning “How to Learn”: Super Declarative Motor Learning Is Impaired in Parkinson’s Disease
  54. Electromyographic assessment of paratonia
  55. Attention in Parkinson’s disease with fatigue: evidence from the attention network test
  56. The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity
  57. In normal aging ventricular system never attains pathological values of Evans' index
  58. Selective attentional deficit in essential tremor: Evidence from the attention network test
  59. Brain 18F-DOPA PET and cognition in de novo Parkinson’s disease
  60. TMS Enhances Retention of a Motor Skill in Parkinson's Disease
  61. Balance Dysfunction in Parkinson’s Disease
  62. Orbitofrontal18F-DOPA Uptake and Movement Preparation in Parkinson’s Disease
  63. Neurophysiological assessment of small midlateral medullary syndromes
  64. Effect of radial shock wave therapy on pain and muscle hypertonia: a double-blind study in patients with multiple sclerosis
  65. Recurring hyperammonemic encephalopathy induced by bacteria usually not producing urease
  66. Poster Presentations
  67. Diffusion magnetic resonance imaging diagnostic relevance in pyogenic ventriculitis with an atypical presentation: a case report
  68. Pathophysiology of Spasticity: Implications for Neurorehabilitation
  69. Shock Waves in the Treatment of Muscle Hypertonia and Dystonia
  70. The effect of age on post-activation depression of the upper limb H-reflex
  71. Postactivation depression changes after robotic-assisted gait training in hemiplegic stroke patients
  72. Manual Linear Movements to Assess Spasticity in a Clinical Setting
  73. Tremor in primary adult-onset dystonia: prevalence and associated clinical features
  74. Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia
  75. Corticospinal excitability in patients with secondary dystonia due to focal lesions of the basal ganglia and thalamus
  76. Diagnostic agreement in patients with psychogenic movement disorders
  77. Eye symptoms in relatives of patients with primary adult-onset dystonia
  78. Basal ganglia and kinematics modulation: Insights from Parkinson’s and Huntington’s diseases
  79. Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm
  80. Continuous involuntary hand movements and schizencephaly: epilepsia partialis continua or dystonia?
  81. In idiopathic cervical dystonia movement direction is inaccurate when reaching in unusual workspaces
  82. Increased reaction time predicts visual learning deficits in Parkinson's disease
  83. Non-convulsive status epilepticus triggered by haemodialysis in an epileptic patient
  84. Effects of treadmill training on walking economy in Parkinson’s disease: a pilot study
  85. Lower limb involvement in adult-onset primary dystonia: frequency and clinical features
  86. Cervical dystonia affects aimed movements of nondystonic segments
  87. External shock waves therapy in dystonia: preliminary results
  88. Learning and consolidation of visuo-motor adaptation in Parkinson's disease
  89. Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease
  90. 1.199 Increased reaction time predicts deficit of explicit visual learning in the early stages of Parkinson's disease
  91. 1.257 Cervical dystonia: Effect of botulinum toxin on trajectory formation
  92. 1.197 Sequence learning and the basal ganglia
  93. Errors in Byline in: A Comparative Study of Primary and Secondary Hemifacial
  94. Primary vs Postparalytic Hemifacial Spasm—Reply
  95. Bilateral impairment of intracortical inhibition in delayed-onset posthemiplegic dystonia: Pathophysiological implications
  96. Creutzfeldt-Jakob disease presenting as corticobasal degeneration: a neurophysiological study
  97. A Comparative Study of Primary and Secondary Hemifacial Spasm
  98. Role of ventricular autocapture function in increasing longevity of DDDR pacemakers: a prospective study
  99. Posturographic analysis of balance control in patients with essential tremor
  100. Relationship between eye symptoms and blepharospasm: A multicenter case–control study
  101. Dyskinesias predict the onset of motor response fluctuations in patients with Parkinson's disease on l-dopa monotherapy
  102. Interhemispheric subdural haematoma from ruptured aneurysm
  103. Muscle relaxation is impaired in dystonia: A reaction time study
  104. Suppression of the transcallosal motor output: a transcranial magnetic stimulation study in healthy subjects
  105. Impairment of transcallosal inhibition in patients with corticobasal degeneration
  106. Differential modulation of motor evoked potential and silent period by activation of intracortical inhibitory circuits
  107. Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
  108. Lipoperoxidation Is Selectively Involved in Progressive Supranuclear Palsy
  109. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy
  110. Tyrosine kinase A-nerve growth factor receptor is antigenically present in dystrophic neurites from a variety of conditions but not in Alzheimer's disease